Evidence map›Paper›PMID 42228332›Full record

Observational studyDrug safety2026

Incidence of Naloxone-Use Before and After Implementing Opioid Safety Measures for Patients Hospitalised on General Wards in a Swiss University Hospital.

Anja Jungo, Kanchan Dongre, Delia Halbeisen, Tobias Schneider, Sibylle Chettata, Niklaus Gygli, Murat Bilici, Christoph R Meier, Anne B Leuppi-Taegtmeyer

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Drug safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anja Jungo *Department of Pharmaceutical Science, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0003-3555-7389
Kanchan Dongre *Department of Patient Safety, Medical Directorate, University Hospital Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0003-3170-8645
Delia HalbeisenHospital Pharmacy, University Hospital Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0001-9630-6597
Tobias SchneiderClinic for Anaesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0001-8792-9872
Sibylle ChettataClinic for Anaesthesia, Intermediate Care, Prehospital Emergency Medicine and Pain Therapy, University Hospital Basel, Basel, Switzerland.
Niklaus GygliDepartment of Nursing, Medical Directorate, University Hospital Basel, Basel, Switzerland.ORCID http://orcid.org/0009-0004-1221-4919
Murat BiliciDepartment of Quality Management, Medical Directorate, University Hospital Basel, Basel, Switzerland.
Christoph R MeierDepartment of Pharmaceutical Science, University of Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-7120-6378
Anne B Leuppi-TaegtmeyerDepartment of Patient Safety, Medical Directorate, University Hospital Basel, Basel, Switzerland. anne.taegtmeyer@unibas.ch.ORCID http://orcid.org/0000-0002-4561-7499

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOpioids are high-risk medications that in overdose can lead to severe life-threatening or fatal adverse drug events. Inadvertent overdose is often the cause of opioid intoxication in hospitals. We introduced digital weight-based as-needed morphine and hydromorphone order sets at our hospital in November 2020 to prevent such adverse events. Naloxone given to reverse life-threatening opioid intoxication (LTOI) is a marker for these events in patient records.

aimThe main aim was to ascertain the incidence of opioid-treated patients requiring naloxone for the management of LTOI on general wards before and after implementation of the order sets.

methodsThis investigator-driven, retrospective, observational, single-centre cohort study investigated naloxone administrations for LTOIs per 1000 opioid-treated patients, and per 1000 inpatients on general wards between 2019 and 2024 at the University Hospital Basel (USB). Prescription data and electronic hospital records were reviewed.

resultsDuring the study period, a total of 78,438 patient cases received prescription opioids, of which 149 required naloxone for LTOIs. The incidence of naloxone-treated LTOIs per 1000 opioid treated patients was 3.21 prior to the introduction of the order sets and declined to 1.46 four years later (55% reduction, p = 0.002). There were 181,314 inpatients during the study period. The incidence of naloxone per 1000 inpatients was 1.14 before and 0.64 four years after the introduction of the order sets (44% reduction, p = 0.023).

conclusionWe observed a significant reduction in the incidence of naloxone use for LTOI following the introduction of digital order sets for as-required morphine and hydromorphone indicating their effect to help promote safe opioid use and to improve patient safety in our hospital.

Indexed as

Analgesics, OpioidDrug OverdoseNaloxoneNarcotic AntagonistsAdultAgedCohort StudiesFemaleHospitalizationHospitals, UniversityHumansIncidenceMaleMiddle AgedMorphineRetrospective StudiesAnalgesics, OpioidMorphineNaloxoneNarcotic Antagonists

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.